AVROBIO Inc. (NASDAQ:AVRO) finished Thursday with a subtraction of $0.0 to close at $1.56, a downside of 0.00 percent. An average of 422,484 shares of common stock have been traded in the last five days. There was a gain of $0.0850 in the past week, and it reached a new high 6 times over the past 12 months. The last 20 days have seen an average of 825,566 shares traded, while the 50-day average volume stands at 1,478,806.
AVRO stock has increased by 10.64% in the last month. The company shares reached their 1-month lowest point of $1.2700 on 07/12/23. With the stock rallying to its 52-week high on 02/10/23, shares of the company touched a low of $0.56 and a high of $1.93 in 52 weeks. It has reached a new high 9 times so far this year and achieved 118.82% or $0.8821 in price. In spite of this, the price is down -19.17% from the 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Valuation Metrics
AVROBIO Inc. (AVRO) stock’s beta is 1.55. Other valuation ratios to consider include the price-to-book (PB) ratio at 1.30.
Financial Health
The quick ratio of AVROBIO Inc. for the three months ended March 30 was 5.40, and the current ratio was 5.40, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.29 and a total debt to equity ratio of 0.29 for the quarter ending March 30.
For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, AVROBIO Inc.’s return on assets was -87.30%.
Earnings Surprise
For the three-month period that ended March 30, AVROBIO Inc. had $15.36 million in total debt. The company posted a net income of -$24.96 million in the quarter, while revenues were shrunk -19.51%. The analyst consensus anticipated AVROBIO Inc.’s latest quarter earnings to come in at -$0.54 per share, but it turned out to be -$0.57, a -5.60% surprise. Shareholders own equity worth $44.1 million.
Technical Picture
From a technical analysis perspective, let’s take a brief look at AVROBIO Inc. (AVRO) price momentum. RSI 9-day as of the close on 10 August was 76.78%, suggesting the stock is Overbought, with historical volatility in this time frame at 17.54%.
As of today, AVRO’s price is $1.5510 +5.63% or $0.0850 from its 5-day moving average. AVRO is currently trading +13.12% higher than its 20-day SMA and +29.67% higher than its 100-day SMA. However, the stock’s current price level is +45.00% above the SMA50 and +134.87% above the SMA200.
The stochastic %K and %D were 82.55% and 73.70%, respectively, and the average true range (ATR) was 0.0721. With the 14-day stochastic at 94.29% and the average true range at 0.0771, the RSI (14) stands at 72.28%. The stock has reached 0.0322 on the 9-day MACD Oscillator while the 14-day reading was at 0.0423.
Analyst Ratings
BTIG Research downgraded AVROBIO Inc. (NASDAQ: AVRO) to a a Neutral rating in its most recent analyst report. Previously, the stock was rated as a Buy. The consensus rating for AVROBIO Inc. (AVRO) among analysts is Overweight. According to current brokerage recommendations, 0 brokerage firms advise that investors sell AVRO, while 1 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 1 analysts, while 3 others rate it as a “buy”.
What is AVRO’s price target for the next 12 months?
Analysts predict a range of price targets between $2.00 and $6.00, with a median target of $4.00. Taking a look at these predictions, the average price target given by analysts for AVROBIO Inc. (AVRO) stock is $3.80.
